EZZ Life Science Holdings Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 5/6
EZZ Life Science Holdings has been growing earnings at an average annual rate of 32.7%, while the Life Sciences industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 31.2% per year. EZZ Life Science Holdings's return on equity is 32.7%, and it has net margins of 10.5%.
Anahtar bilgiler
32.7%
Kazanç büyüme oranı
24.7%
EPS büyüme oranı
| Life Sciences Sektör Büyümesi | 19.7% |
| Gelir büyüme oranı | 31.2% |
| Özkaynak getirisi | 32.7% |
| Net Marj | 10.5% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
EZZ Life Science Holdings Limited (ASX:EZZ) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Nov 04
EZZ Life Science Holdings Limited's (ASX:EZZ) Shares Leap 41% Yet They're Still Not Telling The Full Story
Aug 28EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Jun 05There's No Escaping EZZ Life Science Holdings Limited's (ASX:EZZ) Muted Earnings Despite A 28% Share Price Rise
Apr 02Here's Why We Think EZZ Life Science Holdings (ASX:EZZ) Is Well Worth Watching
Feb 09EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Is Matching Sentiment Around Its Earnings
Oct 18EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations
Mar 06Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)
Nov 22Gelir ve Gider Dağılımı
EZZ Life Science Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 66 | 7 | 38 | 0 |
| 31 Mar 24 | 55 | 5 | 32 | 0 |
| 31 Dec 23 | 44 | 3 | 26 | 0 |
| 30 Sep 23 | 40 | 4 | 24 | 0 |
| 30 Jun 23 | 37 | 4 | 22 | 0 |
| 31 Mar 23 | 31 | 3 | 16 | 0 |
| 31 Dec 22 | 24 | 3 | 11 | 0 |
| 30 Sep 22 | 19 | 2 | 7 | 0 |
| 30 Jun 22 | 15 | 1 | 4 | 0 |
| 31 Mar 22 | 15 | 1 | 5 | 0 |
| 31 Dec 21 | 16 | 1 | 5 | 0 |
| 30 Sep 21 | 19 | 1 | 7 | 0 |
| 30 Jun 21 | 22 | 2 | 9 | 0 |
| 31 Mar 21 | 22 | 2 | 7 | 0 |
| 31 Dec 20 | 21 | 2 | 6 | 0 |
| 30 Sep 20 | 20 | 2 | 4 | 0 |
| 30 Jun 20 | 18 | 2 | 2 | 0 |
| 30 Jun 19 | 11 | 1 | 3 | 0 |
Kaliteli Kazançlar: EZZ has a high level of non-cash earnings.
Büyüyen Kar Marjı: EZZ's current net profit margins (10.5%) are higher than last year (9.8%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: EZZ's earnings have grown significantly by 32.7% per year over the past 5 years.
Büyüme Hızlandırma: EZZ's earnings growth over the past year (91.9%) exceeds its 5-year average (32.7% per year).
Kazançlar vs. Sektör: EZZ earnings growth over the past year (91.9%) exceeded the Life Sciences industry -5.7%.
Özkaynak Getirisi
Yüksek ROE: EZZ's Return on Equity (32.7%) is considered high.